{"id":"https://openalex.org/W265038895","doi":"https://doi.org/10.1007/978-1-59745-197-0_8","title":"Novel Opioid Antagonists with Mixed/Dual Selectivity","display_name":"Novel Opioid Antagonists with Mixed/Dual Selectivity","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W265038895","doi":"https://doi.org/10.1007/978-1-59745-197-0_8","mag":"265038895"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-59745-197-0_8","doi":"https://doi.org/10.1007/978-1-59745-197-0_8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-59745-197-0_8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Opiate Receptors and Antagonists","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2506882304","display_name":"Opiate Receptors and Antagonists"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103446078","display_name":"Richard B. Rothman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]},{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Rothman","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark","University of Medicine and Dentistry of New Jersey\u2013New Jersey Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark","institution_ids":["https://openalex.org/I4402554120","https://openalex.org/I4405286694"]},{"raw_affiliation_string":"University of Medicine and Dentistry of New Jersey\u2013New Jersey Medical School","institution_ids":["https://openalex.org/I4402554120","https://openalex.org/I4405286694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006585063","display_name":"Subramaniam Ananthan","orcid":"https://orcid.org/0000-0002-4791-9116","observed_orcids":["https://orcid.org/0000-0002-4791-9116"]},"institutions":[{"id":"https://openalex.org/I108109523","display_name":"Southern Research Institute","ror":"https://ror.org/0153ngy95","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I108109523"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Subramaniam Ananthan","raw_affiliation_strings":["Organic Chemistry Department, Southern Research Institute, Birmingham","Southern Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Organic Chemistry Department, Southern Research Institute, Birmingham","institution_ids":["https://openalex.org/I108109523"]},{"raw_affiliation_string":"Southern Research Institute","institution_ids":["https://openalex.org/I108109523"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015614509","display_name":"Edward J. Bilsky","orcid":"https://orcid.org/0000-0002-4664-5256","observed_orcids":["https://orcid.org/0000-0002-4664-5256"]},"institutions":[{"id":"https://openalex.org/I275799156","display_name":"University of New England","ror":"https://ror.org/02n2ava60","country_code":"US","type":"education","lineage":["https://openalex.org/I275799156"]},{"id":"https://openalex.org/I90745801","display_name":"University of New England","ror":"https://ror.org/04r659a56","country_code":"AU","type":"education","lineage":["https://openalex.org/I90745801"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Edward J. Bilsky","raw_affiliation_strings":["Department of Pharmacology, University of New England College of Osteopathic Medicine, Biddeford","University of New England - College of Osteopathic Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of New England College of Osteopathic Medicine, Biddeford","institution_ids":["https://openalex.org/I275799156"]},{"raw_affiliation_string":"University of New England - College of Osteopathic Medicine","institution_ids":["https://openalex.org/I275799156","https://openalex.org/I90745801"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.689,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.70683662,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":"137","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.2815000116825104,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.06629999727010727,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.7860000133514404},{"id":"https://openalex.org/keywords/mu-opioid-receptor-agonists","display_name":"mu-opioid receptor agonists","score":0.6940000057220459},{"id":"https://openalex.org/keywords/delta-opioid-receptor-antagonists","display_name":"delta-opioid receptor antagonists","score":0.996999979019165},{"id":"https://openalex.org/keywords/opioid-tolerance","display_name":"opioid tolerance","score":0.6769999861717224},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9509999752044678},{"id":"https://openalex.org/keywords/hydromorphone","display_name":"hydromorphone","score":0.8339999914169312},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.6800000071525574},{"id":"https://openalex.org/keywords/oxymorphone","display_name":"oxymorphone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.902999997138977},{"id":"https://openalex.org/keywords/beta-funaltrexamine","display_name":"beta-funaltrexamine","score":0.8140000104904175},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6942386627197266},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6818081140518188},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6438145041465759},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.5955869555473328},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5894705653190613},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5889906883239746},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.5233094692230225},{"id":"https://openalex.org/C2775962371","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Opioid antagonist","level":5,"score":0.5099061727523804},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5071859359741211},{"id":"https://openalex.org/C2779158186","wikidata":"https://www.wikidata.org/wiki/Q303646","display_name":"Hydromorphone","level":4,"score":0.5026276111602783},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.48284417390823364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3755215108394623},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24355226755142212},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.060934752225875854},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.050984859466552734}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-59745-197-0_8","doi":"https://doi.org/10.1007/978-1-59745-197-0_8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-59745-197-0_8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463399","display_name":"Humana Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310315801","host_organization_name":"Humana Press","host_organization_lineage":["https://openalex.org/P4310315801","https://openalex.org/P4310319900"],"host_organization_lineage_names":["Humana Press","Springer Science+Business Media"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Opiate Receptors and Antagonists","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.766700029373169}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W257048036","https://openalex.org/W1929667086","https://openalex.org/W1970587654","https://openalex.org/W1972225828","https://openalex.org/W1975598246","https://openalex.org/W1983918384","https://openalex.org/W1986100519","https://openalex.org/W1998440016","https://openalex.org/W2006347803","https://openalex.org/W2006413462","https://openalex.org/W2014051345","https://openalex.org/W2026168925","https://openalex.org/W2029463832","https://openalex.org/W2035112609","https://openalex.org/W2045120136","https://openalex.org/W2054982830","https://openalex.org/W2060233031","https://openalex.org/W2063083641","https://openalex.org/W2065668777","https://openalex.org/W2084721137","https://openalex.org/W2085337933","https://openalex.org/W2094109627","https://openalex.org/W2103077095","https://openalex.org/W2108977004","https://openalex.org/W2134387193","https://openalex.org/W2136771602","https://openalex.org/W2143379226","https://openalex.org/W2147122764","https://openalex.org/W2167551539","https://openalex.org/W2433998237","https://openalex.org/W4230381786","https://openalex.org/W4297627420","https://openalex.org/W4406066530"],"related_works":["https://openalex.org/W2108977004","https://openalex.org/W3035149354","https://openalex.org/W2086876254","https://openalex.org/W3175284061","https://openalex.org/W2085337933","https://openalex.org/W2887756694","https://openalex.org/W2143379226","https://openalex.org/W1983918384","https://openalex.org/W4389019235","https://openalex.org/W1975598246"],"abstract_inverted_index":{"Opioid":[0],"analgesics":[1,51,276],"are":[2,65],"the":[3,10,20,45,98,128,138,159,178,191,199,207,219,242,245],"most":[4],"effective":[5],"therapeutic":[6,271],"agents":[7],"available":[8],"for":[9,69,209,277],"treatment":[11,279],"of":[12,25,47,86,100,124,140,174,206,233,238,244,258,280],"moderate":[13],"to":[14,19,34,137,264],"severe":[15],"pain.":[16,281],"In":[17],"addition":[18],"well-known":[21],"opioid":[22,50,71,249],"side":[23],"effects":[24,187],"respiratory":[26],"depression":[27],"and":[28,32,57,79,103,120,131,162],"constipation,":[29],"tolerance,":[30],"dependence,":[31,104],"addiction":[33,62],"prescription":[35],"opioids":[36],"is":[37],"a":[38,87,93,122,150,252],"growing":[39],"problem.":[40],"These":[41,134],"recent":[42],"trends":[43],"emphasize":[44],"importance":[46],"developing":[48,70,110],"new":[49],"that":[52,74,84,113,247],"do":[53,75],"not":[54,76],"produce":[55,77],"tolerance":[56,78,102,200,266],"dependence":[58],"and/or":[59],"have":[60,261,270],"decreased":[61],"liability.":[63],"There":[64],"several":[66],"possible":[67],"strategies":[68],"analgesic":[72],"drugs":[73],"dependence.":[80],"Based":[81],"on":[82,109],"observations":[83],"co-administration":[85],"delta-opioid":[88],"receptor":[89,95],"antagonist":[90,155,193,256],"with":[91,251],"morphine,":[92],"mu-opioid":[94],"agonist,":[96],"attenuated":[97],"development":[99,201,232],"morphine":[101],"we":[105],"focused":[106],"our":[107],"efforts":[108,135],"nonpeptide":[111,248],"ligands":[112,250],"possess":[114],"mixed":[115,253],"agonist/antagonist":[116],"activity.":[117],"We":[118],"synthesized":[119],"evaluated":[121],"series":[123],"pyridomorphinans":[125,142],"derived":[126],"from":[127],"naloxone,":[129],"oxymor-phone,":[130],"hydromorphone":[132],"framework.":[133],"led":[136],"identification":[139],"hydromorphone-derived":[141],"3":[143,210],"[formerly":[144],"14]":[145],"(5\u2032'-(4-chlorophenyl)-6,7-didehydro-4,5\u03b1-epoxy-3-hydroxy-17-methylpyrido[2\u2032,3\u2032:6,7]morphinan,":[146],"SoRI":[147,167,212,239],"20411)":[148],"as":[149],"compound":[151,208],"possessing":[152],"mu":[153,254,274],"agonist/delta":[154,255],"activity":[156,259],"in":[157,177,183,198,218,226],"both":[158],"[35S]-GTP-\u03b3-S":[160],"binding":[161],"smooth":[163],"muscle":[164],"functional":[165],"assays.":[166],"20411":[168,213,240],"produced":[169],"antinociception":[170],"(A50.":[171],"potency":[172,221],"value":[173],"42.8":[175],"nmol":[176],"55\u00b0C":[179],"warm-water":[180],"tail-withdrawal":[181],"assay":[182],"mice).":[184],"The":[185,235],"antinociceptive":[186,220],"were":[188],"blocked":[189],"by":[190],"mu-selective":[192],"\u03b2-funaltrexamine":[194],"(\u03b2-FNA).":[195],"When":[196],"tested":[197],"assays":[202],"involving":[203],"repeated":[204],"injections":[205],"days,":[211],"induced":[214],"an":[215],"insignificant":[216],"shift":[217],"(less":[222],"than":[223],"1.1-fold":[224],"increase":[225],"A50":[227],"value),":[228],"indicating":[229],"very":[230],"little":[231],"tolerance.":[234],"identi":[236],"fication":[237],"demonstrates":[241],"validity":[243],"hypothesis":[246],"profile":[257],"may":[260,269],"diminished":[262],"propensity":[263],"induce":[265],"and,":[267],"therefore,":[268],"advantages":[272],"over":[273],"agonist":[275],"long-term":[278]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2016-06-24T00:00:00"}